{
    "clinical_study": {
        "@rank": "1618", 
        "arm_group": [
            {
                "arm_group_label": "Optimised V-V timing delay", 
                "arm_group_type": "Experimental", 
                "description": "V-V timing delay setting on biventricular pacemaker will be optimised guided by size of R-wave on surface ECG"
            }, 
            {
                "arm_group_label": "Standard V-V timing delay", 
                "arm_group_type": "Active Comparator"
            }
        ], 
        "brief_summary": {
            "textblock": "The aim of this study is to investigate whether the use of a simple feature on the 12 lead\n      electrocardiogram (ECG) to optimise pacemaker device programming can have clinically\n      relevant benefit to patient management. More specifically it is to investigate whether using\n      the R-wave in V1 of the surface ECG to guide the timings between left (LV) and right\n      ventricular (RV) pacing improves response to Cardiac Resynchronisation Therapy."
        }, 
        "brief_title": "R-wave Optimisation in Cardiac Resynchronisation Therapy Study", 
        "condition": "Heart Failure, Systolic", 
        "condition_browse": {
            "mesh_term": [
                "Heart Failure", 
                "Heart Failure, Systolic"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria\n\n          -  The patient must have a biventricular pacemaker in situ, implanted for NYHA Class III\n             / IV heart failure syndrome with impaired systolic function.\n\n          -  Implantation indication must have included a left ventricular ejection fraction\n             measured on transthoracic echo of <35% and either\n\n               -  a QRS duration of >150ms or\n\n               -  a QRS duration of 120 - 149ms with further evidence of dyssynchrony confirmed by\n                  echocardiography.\n\n          -  Participants must have >95% true biventricular pacing over the 1 month before\n             enrolment and throughout the observation period.\n\n          -  The biventricular paced QRS complex morphology in lead V1 of subject's standard 12\n             lead surface ECG must show an R wave height of < 1mm or <20% of the total QRS\n             deflection with standard LV offset settings applied.\n\n          -  The subject's standard 12 lead surface ECG must show a right bundle branch block\n             pattern in lead V1 during LV only pacing.\n\n          -  The participant must be willing to comply with the protocol requirements including\n             travelling to the Royal Bournemouth Hospital for the attendances required for the\n             study and intend to have their long term device follow up at the Royal Bournemouth\n             Hospital at the time of enrolment.\n\n          -  Provision of informed consent Exclusion criteria\n\n          -  Hypertrophic or restrictive cardiomyopathy\n\n          -  Suspected acute myocarditis\n\n          -  Correctable Valvulopathy\n\n          -  An Acute Coronary Syndrome within the last 3 months\n\n          -  Recent (within the last 3 months) or scheduled coronary revascularisation\n\n          -  Treatment resistant hypertension\n\n          -  Severe obstructive lung disease\n\n          -  Pregnancy at the time of enrolment or a desire to become pregnant during the study\n             period\n\n          -  An inability to walk\n\n          -  Reduced life expectancy not associated with cardiovascular disease (less than 1 year)\n\n          -  Unable to provide informed consent"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "25", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 4, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02080000", 
            "org_study_id": "ROC001"
        }, 
        "intervention": [
            {
                "arm_group_label": "Optimised V-V timing delay", 
                "intervention_name": "Optimisation of V-V timing using R wave on surface ECG", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": "Standard V-V timing delay", 
                "intervention_name": "Standard V-V timing settings", 
                "intervention_type": "Other"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Heart Failure", 
            "Cardiac Resynchronisation Therapy", 
            "Biventricular Pacemaker", 
            "Optimisation"
        ], 
        "lastchanged_date": "March 4, 2014", 
        "location": {
            "contact": {
                "last_name": "Robert W Bowers, MBBS", 
                "phone": "01202 303626", 
                "phone_ext": "5820"
            }, 
            "facility": {
                "address": {
                    "city": "Bournemouth", 
                    "country": "United Kingdom", 
                    "state": "Dorset", 
                    "zip": "BH7 7DW"
                }, 
                "name": "Royal Bournemouth Hospital"
            }, 
            "investigator": [
                {
                    "last_name": "Robert W Bowers, MBBS", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "John R Paisey, DM", 
                    "role": "Principal Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United Kingdom"
        }, 
        "number_of_arms": "2", 
        "official_title": "Use of the R-wave to Optimise VV Delay in Heart Failure Patients Treated With Cardiac Resynchronisation Therapy", 
        "other_outcome": [
            {
                "measure": "Hospitalisation for any cause", 
                "safety_issue": "Yes", 
                "time_frame": "3 months"
            }, 
            {
                "measure": "Hospitalisation for Heart Failure", 
                "safety_issue": "Yes", 
                "time_frame": "3 months"
            }
        ], 
        "overall_contact": {
            "last_name": "John R Paisey, MD", 
            "phone": "01202303626"
        }, 
        "overall_contact_backup": {
            "last_name": "Robert W Bowers, MBBS", 
            "phone": "01202 303626", 
            "phone_ext": "5820"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United Kingdom: National Health Service, Research and Development Department", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "March 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Quality of Life Score", 
            "safety_issue": "No", 
            "time_frame": "3 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02080000"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "6 minute hall walk distance", 
                "safety_issue": "No", 
                "time_frame": "3 months"
            }, 
            {
                "measure": "Left Ventricular End Systolic Volume Index", 
                "safety_issue": "No", 
                "time_frame": "3 months"
            }
        ], 
        "source": "The Royal Bournemouth Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "The Royal Bournemouth Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "February 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}